Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.57 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.57 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.57 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760865 | 1.00 | ANPEP (0.57) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL4282969 | 1.00 | ANPEP (0.57) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL28675057 | 0.98 | ANPEP (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL20590185 | 0.98 | ANPEP (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL16988 | 0.98 | ANPEP (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Sulfuric Acid SCHEMBL1605647 | 0.90 | BLM (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Nitric Acid SCHEMBL7055225 | 0.87 | ANPEP (0.50) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL7998233 | 0.86 | GRIK1 (0.54) | ANPEPERAP1ERAP2HTR2ASMN1; SMN2 | |
| SCHEMBL456442 | 0.86 | GRIK1 (0.54) | ANPEPERAP1ERAP2HTR2ASMN1; SMN2 | |
| SCHEMBL14544283 | 0.86 | GRIK1 (0.54) | ANPEPERAP1ERAP2HTR2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2075 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4209246-B1 | METHOD OF MANUFACTURING OF A PARTICLE-ATTACHED MICRONEEDLE | QUADMEDICINE INC (KR) | 2026-02-18 | — | — | EP | claimed |
| EP-3968065-B1 | PLANAR LIGHTING DEVICE | LG ELECTRONICS INC (KR) | 2025-05-28 | — | — | EP | claimed |
| EP-1773302-B2 | RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS | JOHNSON & JOHNSON CONSUMER INC (US) | 2024-06-26 | — | — | EP | claimed |
| EP-4380942-A1 | NOVEL APPLICATIONS FOR OXAZABOROLIDINES AND NEW METHODS OF MANUFACTURE THEREOF | Pathway Intermediates Limited (GB) | 2024-06-12 | — | — | EP | claimed |
| CN-113880721-B | Synthesis method of dapoxetine | 湖南九典制药股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117736399-A | Bio-based polyurethane foam based on lignin oligomer and vegetable oil and preparation method thereof | 中国林业科学研究院林产化学工业研究所 | 2024-03-22 | — | — | CN | claimed |
| US-20230392750-A1 | HIGH-PRESSURE COMPOSITE CONTAINER | YAPP AUTOMOTIVE SYSTEMS CO., LTD (CN) | 2023-12-07 | — | — | US | claimed |
| EP-3697386-B1 | LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS | SIGNPATH PHARMA INC (US) | 2023-07-26 | — | — | EP | claimed |
| EP-4206516-A1 | HIGH-PRESSURE COMPOSITE CONTAINER | Yapp Automotive Systems Co., Ltd. (CN) | 2023-07-05 | — | — | EP | claimed |
| EP-0132472-B1 | MEDICATED PRODUCTS CONTAINING A MAGNESIUM TRISILICATE ADSORBENT WITH A MEDICAMENT DRUG ADSORBED THEREON | WARNER-LAMBERT COMPANY (US) | 1989-06-21 | — | — | EP | claimed |
| EP-0139881-B1 | LIQUID PROLONGED RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING IONIC CONSTITUENTS | PENNWALT CORPORATION (US) | 1989-05-10 | — | — | EP | claimed |
| EP-0123585-B1 | TRANSDERMAL DRUG FORM | RHONE-POULENC SANTE (FR) | 1988-08-31 | — | — | EP | claimed |
| EP-0097523-B1 | EXTENDED ACTION CONTROLLED RELEASE COMPOSITIONS | Euroceltique S.A. (LU) | 1988-01-13 | — | — | EP | claimed |
| US-4639368-A | CARBON DIOXIDE GENERATOR | FARMACON RESEARCH CORPORATION (US) | 1987-01-27 | — | — | US | claimed |
| EP-0173928-A1 | Controlled-release medical preparations | AB LEO (SE) | 1986-03-12 | — | — | EP | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
| US-4522984-A | WITH E-CAPROLACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-11 | — | — | US | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| US-4045450-A | Optical resolution of DL-pantolactone | ALPS PHARMACEUTICAL IND. CO., LTD. (JA) | 1977-08-30 | — | — | US | claimed |